[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[e-drug] Treatment of Hepatitis C Virus Infection
- From: "Chris W. Green" <chrisg@rad.net.id>
- Date: Sat, 19 May 2007 18:27:15 +0700
E-DRUG: Treatment of Hepatitis C Virus Infection
---------------------------------------------
[Is this another sort of 'disease-mongering'?
See E-drug archive Disease Mongering - April 14, 2006.
http://www.essentialdrugs.org/edrug/archive/200604/msg00038.php BS ]
It seems to me that the current treatments for HCV are now being pushed
as hard as possible to 'make hay while the sun shines', before new,
cheaper and more tolerable treatments become available.
Are others seeing a similar push on HCV testing and treatment?
I am becoming increasingly concerned over what appears to be somewhat
questionable 'marketing' of hepatitis C virus (HCV) infection in
Indonesia. People are being encouraged to test for HCV in order to be sure
that they are 'free' of the the virus, so that they do not 'become a time
bomb for their community and those they love' (translation of a Roche
Indonesia release).
What I see happening again and again is that people are being encouraged
to take an antibody test for HCV, without being aware that if the result
is positive, this may not indicate chronic infection, and that they will
have to have a viral load test to confirm this. The cost of such a test is
prohibitive for most, as well as being very difficult to access.
The release also notes that HCV infection may be cured. It fails to note
the challenges involved in the possible cure, or that there is still some
controversy over whether HCV infection can indeed be cured. People, mostly
co-infected with HIV, are being encouraged to start this treatment,
without being aware that they really need an (expensive) genotype test
first, without being aware of the low cure rate, and without being aware
of the excruciating side effects that often continue almost unabated for
the period of treatment (usually 12 months). They are also unaware that of
the huge cost. They are often not informed that one element of the therapy
is teratogenic, even if only taken by the male partner.
Co-infected folk are also being encouraged to start HCV treatment even
with CD4 counts in their teens!
It is my understanding that HCV treatment is rarely an emergency, and that
the current treatment situation is similar to that for HIV in the mid-
1990's, with a number of new and much more tolerable drugs in the
pipeline. It seems to me that the current treatments are now being pushed
as hard as possible to 'make hay while the sun shines', before new,
cheaper and more tolerable treatments become available.
I am indeed very concerned over the rates of HIV/HCV co-infection in what
is here a largely injecting drug use-driven HIV epidemic. But while those
co-infected are fairly comfortable about their HIV infection (with better
access to information and treatment), they view their HCV infection as a
'black hole', with poor access to information, and a lack of health care
providers who fully understand both infections and their interactions.
This leaves them very vulnerable to pressure such as this.
It is my view that many HIV-infected drug users may be better off not
being tested for HCV, since they cannot possibly afford the viral load
test, let alone the genotype test or the treatment. This should be
explained to them, but they should probably not be encouraged to have the
test, which (for IDUs) will almost certainly be positive, but which only
leaves them more confused.
Amazingly, it is much less common here for those with HIV infection to be
tested for hepatitis B virus (HBV) infection. This is an infection which
can be prevented, can be treated more easily, but which can be adversely
affected by thoughtless antiretroviral therapy.
Chris
--
Chris W. Green (wartaaids@gmail.com)
AIDS Treatment Educator, Spiritia Foundation
Jakarta, Indonesia
Tel: +62 (21) 422-5163 Fax: +62 (21) 4287 1866
Web site: <http://spiritia.or.id>
"Chris W. Green" <chrisg@rad.net.id>
|